D’OXYVA improves dermal microcirculation and promotes wound healing in the diabetic foot (clinical trial update)
Prof. Puruhito and colleagues have released the results of three observational trials showing that D’OXYVA® (Circularity Healthcare LLC), a deoxyhemoglobin vasodilator, improves vasodilation in the treatment of diabetic foot ulcers (DFUs), boosts dermal microcirculation, and helps in the healing process of DFUs. D’OXYVA® is a circulatory and nerve